These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Specific serum IgG, but not IgA, antibody against purified Opisthorchis viverrini antigen associated with hepatobiliary disease and cholangiocarcinoma. Pinlaor P, Pongsamart P, Hongsrichan N, Sangka A, Srilunchang T, Mairiang E, Sithithaworn P, Pinlaor S. Parasitol Int; 2012 Mar; 61(1):212-6. PubMed ID: 21718798 [Abstract] [Full Text] [Related]
3. Hepatobiliary morbidities detected by ultrasonography in Opisthorchis viverrini-infected patients before and after praziquantel treatment: a five-year follow up study. Mairiang E, Laha T, Kaewkes S, Loukas A, Bethony J, Brindley PJ, Sripa B. Acta Trop; 2021 May; 217():105853. PubMed ID: 33548204 [Abstract] [Full Text] [Related]
18. Association of comorbidity between Opisthorchis viverrini infection and diabetes mellitus in the development of cholangiocarcinoma among a high-risk population, northeastern Thailand. Thinkhamrop K, Khuntikeo N, Laohasiriwong W, Chupanit P, Kelly M, Suwannatrai AT. PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009741. PubMed ID: 34543283 [Abstract] [Full Text] [Related]